IVORX | VMVAX | IVORX / VMVAX | |
Total Expense Ratio | 1.33 | 0.07 | 1,900% |
Annual Report Gross Expense Ratio | 1.50 | 0.07 | 2,143% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | -6.421 | -6.304 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 869M | 29.9B | 3% |
Annual Yield % from dividends | 1.20 | 2.33 | 52% |
Returns for 1 year | -7.61 | 3.43 | -222% |
Returns for 3 years | -5.23 | 2.21 | -237% |
Returns for 5 years | 47.52 | 71.82 | 66% |
Returns for 10 years | 64.57 | 67.22 | 96% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EJAN | 29.43 | -0.10 | -0.34% |
Innovator Emerging Mkt Pwr Buff ETF™ Jan | |||
DFEV | 25.66 | -0.18 | -0.70% |
Dimensional Emerging Markets Value ETF | |||
BDCZ | 16.84 | -0.13 | -0.75% |
UBS ETRACS Wells Fargo® Busn Dev Co ETN | |||
KJAN | 34.12 | -0.35 | -1.03% |
Innovator US Small Cap Pwr Buff ETF™ Jan | |||
DYNF | 45.90 | -1.03 | -2.19% |
iShares U.S. Equity Fac Rotation Act ETF |